Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors

By sjmartinez • August 19, 2024

Mederos MA, Court CM, Dipardo BJ, Pisegna JR, Dawson DW, Joe Hines O, Donahue TR, Graeber TG, Girgis MD, Tomlinson JS. Oncogenic pathway signatures predict the risk of progression and recurrence in well-differentiated pancreatic neuroendocrine tumors. J Surg Oncol. 2024 Aug 19. doi: 10.1002/jso.27830. Epub ahead of print. PMID: 39155697.

Tags: Digestive Diseases, genomic biomarker, pancreatic neuroendocrine tumor, prognosis, Publications, recurrence, Veterans Administration, whole‐exome sequencing

Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Rex DK, Anderson JC, Burke CA, Jacobson BC, May FP, Patel SG, Samadder NJ, Stoffel EM, Robertson DJ. Serrated Polyposis Syndrome: A Review and Consensus[...]

Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Rex DK, Anderson JC, Burke CA, Jacobson BC, May FP, Patel SG, Samadder NJ, Stoffel EM, Robertson DJ. Serrated Polyposis Syndrome: A Review and Consensus[...]

Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer

Rex DK, Anderson JC, Burke CA, Jacobson BC, May FP, Patel SG, Samadder NJ, Stoffel EM, Robertson DJ. Serrated Polyposis Syndrome: A Review and Consensus[...]